WDR3 Gene Haplotype Is Associated with Thyroid Cancer Risk in a Spanish Population
Abstract
Background: A member of the genes encoding WD-repeat proteins, the WDR3 gene, maps in the 1p12 region. This region was shown to be associated with thyroid cancer susceptibility in a previous work. In this study we aim to evaluate the contribution of WDR3 to thyroid cancer risk.
Methods: A case–control association study was performed in a total of 402 patients and 479 control subjects from a Spanish population. In the initial phase of the study, 10 single-nucleotide polymorphisms covering the WDR3 region were genotyped in a small group (157 patients and 118 control subjects); next, three of the initial single-nucleotide polymorphisms were further genotyped in the overall population. In addition, WDR3 expression was investigated in 10 thyroid cancer cell lines by RT-PCR and Western blot.
Results: Haplotype analysis revealed that combination of certain WDR3 variants, such as haplotype CAT, increases the risk of thyroid cancer (odds ratio = 1.85, 95% confidence interval = 0.97–3.55, p = 0.063). Further, both messenger RNA transcription and protein expression of WDR3 were altered in human thyroid cancer cells.
Conclusion: These results indicate for the first time that WDR3 is a risk factor to thyroid cancer, suggesting its implication in the etiology of thyroid cancer.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Sherman SI2003. Thyroid carcinomaLancet361501-511. 1. Sherman SI 2003 Thyroid carcinoma. Lancet 361:501–511.
2.
Kondo TEzzat SAsa SL2006. Pathogenetic mechanisms in thyroid follicular-cell neoplasiaNat Rev Cancer6292-306. 2. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292–306.
3.
Hunt JL2002. Molecular mutations in thyroid carcinogenesisAm J Clin Pathol118SupplS116-S127. 3. Hunt JL 2002 Molecular mutations in thyroid carcinogenesis. Am J Clin Pathol 118 Suppl:S116–S127.
4.
Baida AFarrington SMGalofre PMarcos RVelazquez A2005. Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphismsCancer Epidemiol Biomarkers Prev14638-642. 4. Baida A, Farrington SM, Galofre P, Marcos R, Velazquez A 2005 Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphisms. Cancer Epidemiol Biomarkers Prev 14:638–642.
5.
Baida AAkdi MGonzalez-Flores EGalofre PMarcos RVelazquez A2008. Strong association of chromosome 1p12 loci with thyroid cancer susceptibilityCancer Epidemiol Biomarkers Prev171499-1504. 5. Baida A, Akdi M, Gonzalez-Flores E, Galofre P, Marcos R, Velazquez A 2008 Strong association of chromosome 1p12 loci with thyroid cancer susceptibility. Cancer Epidemiol Biomarkers Prev 17:1499–1504.
6.
Jazdzewski KMurray ELFranssila KJarzab BSchoenberg DRde la CA2008. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinomaProc Natl Acad Sci U S A1057269-7274. 6. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la CA 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105:7269–7274.
7.
Gudmundsson JSulem PGudbjartsson DFJonasson JGSigurdsson ABergthorsson JTHe HBlondal TGeller FJakobsdottir MMagnusdottir DNMatthiasdottir SStacey SNSkarphedinsson OBHelgadottir HLi WNagy RAguillo EFaure EPrats ESaez BMartinez MEyjolfsson GIBjornsdottir USHolm HKristjansson KFrigge MLKristvinsson HGulcher JRJonsson TRafnar THjartarsson HMayordomo JIde la CAHrafnkelsson JThorsteinsdottir UKong AStefansson K2009. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populationsNat Genet41460-464. 7. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la CA, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460–464.
8.
He HNagy RLiyanarachchi SJiao HLi WSuster SKere Jde la CA2009. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24Cancer Res69625-631. 8. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, de la CA 2009 A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625–631.
9.
Claudio JOLiew CCMa JHeng HHStewart AKHawley RG1999. Cloning and expression analysis of a novel WD repeat gene, WDR3, mapping to 1p12-p13Genomics5985-89. 9. Claudio JO, Liew CC, Ma J, Heng HH, Stewart AK, Hawley RG 1999 Cloning and expression analysis of a novel WD repeat gene, WDR3, mapping to 1p12-p13. Genomics 59:85–89.
10.
van der Voorn LPloegh HL1992. The WD-40 repeatFEBS Lett307131-134. 10. van der Voorn L, Ploegh HL 1992 The WD-40 repeat. FEBS Lett 307:131–134.
11.
Smith TFGaitatzes CSaxena KNeer EJ1999. The WD repeat: a common architecture for diverse functionsTrends Biochem Sci24181-185. 11. Smith TF, Gaitatzes C, Saxena K, Neer EJ 1999 The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 24:181–185.
12.
Li DRoberts R2001. WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseasesCell Mol Life Sci582085-2097. 12. Li D, Roberts R 2001 WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci 58:2085–2097.
13.
Davis LEngebrecht J1998. Yeast dom34 mutants are defective in multiple developmental pathways and exhibit decreased levels of polyribosomesGenetics14945-56. 13. Davis L, Engebrecht J 1998 Yeast dom34 mutants are defective in multiple developmental pathways and exhibit decreased levels of polyribosomes. Genetics 149:45–56.
14.
Bieche IChampeme MHMatifas FCropp CSCallahan RLidereau R1993. Two distinct regions involved in 1p deletion in human primary breast cancerCancer Res531990-1994. 14. Bieche I, Champeme MH, Matifas F, Cropp CS, Callahan R, Lidereau R 1993 Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53:1990–1994.
15.
Zhang JGlatfelter AATaetle RTrent JM1999. Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanomaCancer Genet Cytogenet111119-123. 15. Zhang J, Glatfelter AA, Taetle R, Trent JM 1999 Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma. Cancer Genet Cytogenet 111:119–123.
16.
Tamimi YZiebart KDesaulniers NDietrich KGrundy P2007. Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumorGenes Chromosomes Cancer46327-335. 16. Tamimi Y, Ziebart K, Desaulniers N, Dietrich K, Grundy P 2007 Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor. Genes Chromosomes Cancer 46:327–335.
17.
Chen YLiou CPTseng HHJan YJLi CFTzeng CC2009. Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumorsJ Formos Med Assoc10828-37. 17. Chen Y, Liou CP, Tseng HH, Jan YJ, Li CF, Tzeng CC 2009 Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumors. J Formos Med Assoc 108:28–37.
18.
Chernova OBHunyadi AMalaj EPan HCrooks CRoe BCowell JK2001. A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cellsOncogene205378-5392. 18. Chernova OB, Hunyadi A, Malaj E, Pan H, Crooks C, Roe B, Cowell JK 2001 A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells. Oncogene 20:5378–5392.
19.
Honore BBaandrup UNielsen SVorum H2002. Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreasOncogene211123-1129. 19. Honore B, Baandrup U, Nielsen S, Vorum H 2002 Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas. Oncogene 21:1123–1129.
20.
Proikas-Cezanne TWaddell SGaugel AFrickey TLupas ANordheim A2004. WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagyOncogene239314-9325. 20. Proikas-Cezanne T, Waddell S, Gaugel A, Frickey T, Lupas A, Nordheim A 2004 WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 23:9314–9325.
21.
Silva FPHamamoto RNakamura YFurukawa Y2005. WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferationNeoplasia7348-355. 21. Silva FP, Hamamoto R, Nakamura Y, Furukawa Y 2005 WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation. Neoplasia 7:348–355.
22.
Barrett JCFry BMaller JDaly MJ2005. Haploview: analysis and visualization of LD and haplotype mapsBioinformatics21263-265. 22. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
23.
Sole XGuino EValls JIniesta RMoreno V2006. SNPStats: a web tool for the analysis of association studiesBioinformatics221928-1929. 23. Sole X, Guino E, Valls J, Iniesta R, Moreno V 2006 SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928–1929.
24.
Landa IRuiz-Llorente SMontero-Conde CInglada-Perez LSchiavi FLeskela SPita GMilne RMaravall JRamos IAndia VRodriguez-Poyo PJara-Albarran AMeoro Adel PCArribas LIglesias PCaballero JSerrano JPico APomares FGimenez GLopez-Mondejar PCastello RMerante-Boschin IPelizzo MRMauricio DOpocher GRodriguez-Antona CGonzalez-Neira AMatias-Guiu XSantisteban PRobledo M2009. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factorsPLoS Genet5e1000637. 24. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, Andia V, Rodriguez-Poyo P, Jara-Albarran A, Meoro A, del PC, Arribas L, Iglesias P, Caballero J, Serrano J, Pico A, Pomares F, Gimenez G, Lopez-Mondejar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodriguez-Antona C, Gonzalez-Neira A, Matias-Guiu X, Santisteban P, Robledo M 2009 The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5:e1000637.
25.
Takahashi MSaenko VARogounovitch TIKawaguchi TDrozd VMTakigawa-Imamura HAkulevich NMRatanajaraya CMitsutake NTakamura NDanilova LILushchik MLDemidchik YEHeath SYamada RLathrop MMatsuda FYamashita S2010. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in ChernobylHum Mol Genet2010Apr5[Epub ahead of print]. 25. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S 2010 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 2010 Apr 5 [Epub ahead of print].
26.
McMahon MAyllón VPanov KIO'Connor R2010. Ribosomal 18S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferationJ Biol Chem2010Apr14[Epub ahead of print]. 26. McMahon M, Ayllón V, Panov KI, O'Connor R 2010 Ribosomal 18S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation. J Biol Chem 2010 Apr 14 [Epub ahead of print].
Information & Authors
Information
Published In
Copyright
Copyright 2010, Mary Ann Liebert, Inc.
History
Published online: 6 July 2010
Published in print: July 2010
Published ahead of print: 26 June 2010
Topics
Authors
Disclosure Statement
The authors declare that no competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.